US 12,351,816

Application 18/363,453 · Granted Jul 8, 2025

Cns gene delivery using peripheral administration of aav vectors

Estimated expiration

July 22, 2028

1y 244d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2008059595: Resource not found (404)
Earliest effective filing
Jul 22, 2008
+ 20 years
Jul 22, 2028
PTA +0d
Jul 22, 2028
TD applied
Jul 22, 2028
Final
Jul 22, 2028

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
August 1, 2023
Earliest effective filing
July 22, 2008
Issue date
July 8, 2025
PTA
0 days
Base expiry (before PTA)
July 22, 2028

July 22, 2008 + 20 years = July 22, 2028

  • Continuation of application 16/214,214, filed Dec 10, 2018
  • Continuation of application 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
  • National stage entry of application PCTEP2008059595, filed Jul 22, 2008
  • National stage entry of application PCTEP2008059595, filed Jul 22, 2008
  • Continuation of application 12/452,789, filed Jan 22, 2010, issued as US 10,208,318
  • National stage entry of application PCTEP2008059595, filed Jul 22, 2008

Terminal disclaimers

TD approved2 approved, 2 filed

TD caps expiration to July 22, 2028

  • US 12,351,816· Application 18/363,453(from application 18/363,453)Capping patent

    Cns gene delivery using peripheral administration of aav vectors

    Filing date
    Aug 1, 2023
    Earliest effective filing
    Jul 22, 2008
    Issue date
    Jul 8, 2025
    PTA
    0 days
    Calculated expiration
    Jul 22, 2028

    Continuation of 16/214,214, filed Dec 10, 2018

    Continuation of 12/452,789, filed Jan 22, 2010, issued as US 10,208,318

    National stage entry of PCTEP2008059595, filed Jul 22, 2008

    National stage entry of PCTEP2008059595, filed Jul 22, 2008

    Continuation of 12/452,789, filed Jan 22, 2010, issued as US 10,208,318

    National stage entry of PCTEP2008059595, filed Jul 22, 2008

    Jul 22, 2008 + 20y = Jul 22, 2028

  • US 10,208,318· Application 12/452,789

    Cns gene delivery using peripheral administration of aav vectors

    Filing date
    Jan 22, 2010
    Earliest effective filing
    Jul 22, 2008
    Issue date
    Feb 19, 2019
    PTA
    0 days
    Calculated expiration
    Jul 22, 2028

    National stage entry of PCTEP2008059595, filed Jul 22, 2008

    Jul 22, 2008 + 20y = Jul 22, 2028

  • US 9,926,574· Application 12/734,016

    Widespread gene delivery to motor neurons using peripheral injection of aav vectors

    Filing date
    May 28, 2010
    Earliest effective filing
    Oct 3, 2008
    Issue date
    Mar 27, 2018
    PTA
    +158 days
    Calculated expiration
    Mar 10, 2029

    National stage entry of PCTEP2008063297, filed Oct 3, 2008

    Oct 3, 2008 + 20y + 158d PTA = Mar 10, 2029

  • US 11,767,538· Application 16/536,503

    Widespread gene delivery to motor neurons using peripheral injection of aav vectors

    Filing date
    Aug 9, 2019
    Earliest effective filing
    Oct 3, 2008
    Issue date
    Sep 26, 2023
    PTA
    0 days
    Calculated expiration
    Oct 3, 2028

    Divisional of 15/713,347, filed Sep 22, 2017

    Divisional of 12/734,016, filed May 28, 2010, issued as US 9,926,574

    National stage entry of PCTEP2008063297, filed Oct 3, 2008

    National stage entry of PCTEP2008063297, filed Oct 3, 2008

    Divisional of 12/734,016, filed May 28, 2010, issued as US 9,926,574

    National stage entry of PCTEP2008063297, filed Oct 3, 2008

    Oct 3, 2008 + 20y = Oct 3, 2028

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/363,453 · US 12,351,816

PatentReply compiles the prosecution history behind US 12,351,816: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12351816

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.